Having completed his Pharm-D in 2018 from RGUHS, India, Siavash Shahbazi Nia joined the Graduate Program at Texas Tech University Health Sciences Center in 2019. Siavash's research focuses on medicinal chemistry, and he is interested in developing novel ligands targeting opioid receptors. His project includes the design and synthesis of selective kappa-opioid ligands as a potential therapy for neuropathic pain. Siavash is a member of Dr. German research group.